UPDATE : Monday, September 7, 2020
상단여백
NIBEC wins patent for peptide-based inducible pluripotent stem cell in US by Lee Han-soo 2018-07-04 13:30
Biopharma stocks listed in H1 perform poorer than non-pharma peers by Nam Doo-hyun 2018-07-03 15:08
Beijing Northland to go ahead with P3 clinical trials for VM202 in China by Lee Han-soo 2018-06-29 15:44
Biogen purchases Samsung Bioepis’ share by Lee Han-soo 2018-06-29 14:23
LG Chem launches Enbrel biosimilar in Korea by Lee Han-soo 2018-06-28 12:23
라인
Prognostic marker for childhood obesity complications wins patent by Nam Doo-hyun 2018-06-27 12:19
Antarctic sea microorganisms; a solution to blood shortage? by Nam Doo-hyun 2018-06-26 14:44
Over 60% of KOSDAQ biotech firms mark falls in Q1 operating profit by Nam Doo-hyun 2018-06-19 11:43
Celltrion completes FDA resubmission for Trastuzumab biosimilar by Lee Han-soo 2018-06-18 17:43
Oral care probiotics research on rise by Marian Chu 2018-06-18 15:20
라인
SCM, Toolgen to develop new stem cell treatment by Lee Han-soo 2018-06-15 15:21
NIBEC wins to stem cell regeneration patent by Lee Han-soo 2018-06-15 14:43
Nature Cell suspected of manipulating stock prices by Lee Han-soo 2018-06-12 17:54
Celltrion launches new business platform by Lee Han-soo 2018-06-05 17:49
Bio group takes part in US investment conference by Lee Han-soo 2018-06-04 16:14
라인
Nature Cell applies for P3 clinical trials by Lee Han-soo 2018-06-01 15:43
Biosimilars quickly catch up with originals in Korea by So Jae-hyeon 2018-06-01 15:37
Korean biosimilar makers tap into Japan by So Jae-hyeon 2018-05-30 15:41
LG Chem launches Enbrel biosimilar in Japan by Lee Han-soo 2018-05-30 14:31
Will biotech stocks rebound on listings in H2? by So Jae-hyeon 2018-05-30 11:33
여백
여백
여백
Back to Top